Our results showed that the core components of the Hippo pathway (Mst1/2, LATS1, and Mob1) and the RASSF1 protein coimmunoprecipitated and that their binding was significantly enhanced by rhBMP-2 treatment in both esophageal cancer cell lines. The gene discussed is MOB1A; the disease is esophageal cancer.